Resources

Join the Community

This content is exclusively available to our members. Unlock access to premium resources by joining the community today—don’t miss out on valuable insights and exclusive materials! Become a member now!

Product Information • August 10, 2026

TFOS DEWS III Is Here: Is Your Practice Ready to Evolve Beyond Artificial Tears?

The landscape of dry eye management has shifted. With the release of the TFOS DEWS III: Diagnostic Methodology report, the clinical consensus is clearer than ever: dry eye disease (DED) is a complex, progressive loss of ocular surface homeostasis requiring targeted, etiology-driven intervention. Yet, patients are still managing DED with over-the-counter artificial tears, masking progressive tissue damage while their underlying drivers go…

Education & Awareness, Product Information • August 5, 2026

Getting the Dry Eye Care You Need, Even When Cost Feels Like a Barrier

If you live with moderate to severe dry eye disease, you already know it's not just an occasional irritation. It can affect the clarity of your vision, make it harder to get through a workday, and wear on your mood and energy over time. For many people, the bigger frustration isn't just the symptoms —…

Product Information • August 5, 2026

Eye Really Care: Improving Access to Dry Eye Care

Moderate to severe dry eye disease is far more than an occasional irritation. For many individuals, it can significantly impact visual quality, productivity, daily functioning, and even mental well-being. Eye Really Care was founded to address a critical gap in access to care. Many patients who would benefit from advanced dry eye treatments are unable to receive them because of…

Education & Awareness, Preventative Care • July 23, 2026

Diagnosing Dry Eye in Three Steps: The DEWS III Pathway

Ask ten clinicians how they diagnose dry eye and you may get ten different routines. The surveys Tear Film and Ocular Surface Society (TFOS) ran around DEWS II and again ahead of DEWS III confirmed it: clinicians were using, on average, nine separate tests to reach a diagnosis. That is not thoroughness, it is drift, and it undermines…

Product Information • July 23, 2026

TFOS DEWS III: What Actually Changes for Your Dry Eye Practice

Eight years after the landmark Tear Film and Ocular Surface Society TFOS) DEWS II reports, the TFOS has consolidated the evidence again. The TFOS DEWS III Management and Therapy Report, published in the American Journal of Ophthalmology (Jones et all., 2025), reflects the volume of work published since 2017. For Canadian optometrists, the headline is encouraging: the framework is now simpler to apply at the chair, and…

Education & Awareness, Wellness & Lifestyle • June 25, 2026

From Nine Tests to Three Steps: Professor James Wolffsohn on DEWS III

Sponsored by Espanione Group One in three adults carries a dry eye diagnosis, and most are still underdiagnosed and undertreated. TFOS DEWS III is the most significant update to how we define, diagnose and treat the disease, and is genuinely easier to use at the chair. Join Professor James Wolffsohn, Professor and Dean of Optometry at Aston University and a member of…

Education & Awareness • June 17, 2026

Eye Care Edge Academy: Your Destination for mydryeye

The new and improved Eye Care Edge Academy brings all your learning into one place: mydryeye training modules and supplier partner educational resources, searchable and ready when you need them. Whether you're building new skills, refreshing your knowledge, or onboarding your team, Eye Care Edge Academy is designed to meet you where you are. Eye…

Product Information • June 9, 2026

Beyond Temporary Comfort: Thealoz GEL Can Help You Find Relief That Lasts

Beyond Temporary Comfort: Thealoz GEL Can Help You Find Relief That Lasts If you struggle with dry eye disease, you already know how exhausting it is. If you’re staring at a computer screen all day or even relaxing in an air-conditioned room, that gritty, burning feeling can ruin your day. Temporary drops might feel good for a minute, but the relief…

Diagnosis, Treatment, Management, Education & Awareness, Product Information • June 4, 2026

Why Upper Eyelids Matter

Why Upper Eyelids Matter: Dr. Paul Karpecki Breaks Down New Evidence to Transform Your Meibomian Gland AssessmentSponsored by Meivertor If you are only imaging the lower lids, you might be missing half the story. While upper eyelid meibography is often skipped in routine dry eye workups, emerging data reveals it frequently shows earlier, more severe, and more predictive gland changes than the lower…

Education & Awareness, Preventative Care, Wellness & Lifestyle • May 27, 2026

The Overlap Between Ocular Allergy and DED

Ocular allergy and dry eye disease (DED) frequently coexist, sharing overlapping symptoms, inflammatory pathways and patient frustration. During the allergy seasons, many patients labelled as ‘dry eye failures’ may be experiencing an unrecognized allergic component, or vice versa. Effectively differentiating and managing both conditions is critical to improving outcomes and patient satisfaction. Pathophysiological Interplay Ocular allergy induces a Type I hypersensitivity response, characterized by mast cell degranulation and…